Mohammed Ilyes BELHAYARA

Dr. Mohammed Ilyes BELHAYARA


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MBMohammed Ilyes BELHAYARA
Mohammed Ilyes BELHAYARA
ZMZoheir MELLOUK
Zoheir MELLOUK
MHMohammed Seddik Hamdaoui
Mohammed Seddik Hamdaoui
MBMalika Bachaoui
Malika Bachaoui
OKOmar Kheroua
Omar Kheroua
WMWilly J. Malaisse
Willy J. Malaisse
Several biological markers have been identified as risk factors for cardiovascular disease and are associated with increased risk of metabolic syndrome (MetS). This study provides a factual information on promising biomarkers that are associated with MetS and can aid in early detection and management of MetS in young adults of Western Algeria. We studied a total of one hundred subjects aged between thirty and forty years with MetS, in which anthropometric measurements, insulin resistance, C peptide and HbA1c, lipid profile, circulating adipokines and glucagon-like peptide-1 were measured by suitable methods, in comparison to two groups of control. MetS is closely linked to altered glucose homeostasis, the plasma insulin/glucose ratio; i.e., the insulinogenic index helps to estimate the level of insulin secretion and also for assessing β-cell function. The correlation between homeostasis model assessment insulin resistance index (HOMA-IR) and HbA1c, body mass index or plasma triglycerides yielded positive and significant values. Biomarkers with a known and predictable association with MetS can provide a means to detect those at risk and intervene as needed. This could significantly decrease the burden complications impose on patients and the healthcare system.